Current controversies in determining the main mechanisms of atrial fibrillation

Journal of Internal Medicine

Volumn 279, Issue 5, 2016, Pages 428-438

  Schotten, U ^a   Dobrev, D ^b   Platonov, P G ^c   Kottkamp, H ^d   Hindricks, G ^e  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c LUND UNIVERSITY   (Sweden)

^d KLINIK HIRSLANDEN   (Switzerland)

^e UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Atrial fibrillation; Ca2+ handling; Fibrosis; Multiple wavelet hypothesis; Rotors

Indexed keywords

ANTICOAGULANT THERAPY; ATRIAL FIBRILLATION; CALCIUM SIGNALING; CARDIAC PATIENT; CARDIOMYOPATHY; ELECTROCARDIOGRAM; ELECTROGRAPHY; GAIN OF FUNCTION MUTATION; HEART ATRIUM CONDUCTION; HEART ATRIUM PACING; HOMEOSTASIS; HUMAN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; WAVELET ANALYSIS; ANIMAL; DISEASE MODEL; DOG; MOUSE; PHYSIOLOGY; VASCULAR REMODELING;

ANIMALS; ATRIAL FIBRILLATION; CALCIUM SIGNALING; DISEASE MODELS, ANIMAL; DOGS; HUMANS; MICE; VASCULAR REMODELING;

EID: 84961221539     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12492     Document Type: Review

References (64)

1. Kirchhof P, Breithardt G, Aliot E et al. Personalized management of atrial fibrillation: proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. Europace. 2013;15:1540-56.
2. Lau DH, Volders PG, Kohl P et al. Opportunities and challenges of current electrophysiology research: a plea to establish 'translational electrophysiology' curricula. Europace 2015; 17: 825-33.
3. Heijman J, Voigt N, Nattel S, Dobrev D. Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression. Circ Res 2014; 114: 1483-99.
4. Sood S, Chelu MG, vanOort RJ et al. Intracellular calcium leak due to FKBP12.6 deficiency in mice facilitates the inducibility of atrial fibrillation. Heart Rhythm. 2008;5:1047-54.
5. Beavers DL, Wang W, Ather S et al. Mutation E169K in junctophilin-2 causes atrial fibrillation due to impaired RyR2 stabilization. J Am Coll Cardiol 2013; 62: 2010-9.
6. Shan J, Xie W, Betzenhauser M et al. Calcium leak through ryanodine receptors leads to atrial fibrillation in 3 mouse models of catecholaminergic polymorphic ventricular tachycardia. Circ Res 2012; 111: 708-17.
7. 2+ leak promotes atrial fibrillation in mice. J Clin Investig 2009; 119: 1940-51.
8. Li N, Wang T, Wang W et al. Inhibition of CaMKII phosphorylation of RyR2 prevents induction of atrial fibrillation in FKBP12.6 knockout mice. Circ Res 2012; 110: 465-70.
9. Vest JA, Wehrens XH, Reiken SR et al. Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation 2005; 111: 2025-32.
10. Yeh YH, Wakili R, Qi XY et al. Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure. Circ Arrhythm Electrophysiol 2008; 1: 93-102.
11. Greiser M, Neuberger HR, Harks E et al. Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillation. J Mol Cell Cardiol 2009; 46: 385-94.
12. Hove-Madsen L, Llach A, Bayes-Genis A et al. Atrial fibrillation is associated with increased spontaneous calcium release from the sarcoplasmic reticulum in human atrial myocytes. Circulation 2004; 110: 1358-63.
13. Neef S, Dybkova N, Sossalla S et al. CaMKII-dependent diastolic SR Ca2 + leak and elevated diastolic Ca2 + levels in right atrial myocardium of patients with atrial fibrillation. Circ Res 2010; 106: 1134-44.
14. 2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation. Circulation 2012; 125: 2059-70.
15. 2+ signaling in atrial myocytes. J Clin Investig 2014; 124: 4759-72.
16. Wakili R, Yeh YH, Yan QX et al. Multiple potential molecular contributors to atrial hypocontractility caused by atrial tachycardia remodeling in dogs. Circ Arrhythm Electrophysiol. 2010;3:530-41.
17. Grandi E, Pandit SV, Voigt N et al. Human atrial action potential and Ca2 + model: sinus rhythm and chronic atrial fibrillation. Circ Res 2011; 109: 1055-66.
18. Voigt N, Heijman J, Wang Q et al. Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation. Circulation 2014; 129: 145-56.
19. Christ T, Rozmaritsa N, Engel A et al. Arrhythmias, elicited by catecholamines and serotonin, vanish in human chronic atrial fibrillation. Proc Natl Acad Sci USA 2014; 111: 11193-8.
20. Li N, Chiang DY, Wang S et al. Ryanodine receptor-mediated calcium leak drives progressive development of an atrial fibrillation substrate in a transgenic mouse model. Circulation 2014; 129: 1276-85.
21. King JH, Zhang Y, Lei M, Grace AA, Huang CL, Fraser JA. Atrial arrhythmia, triggering events and conduction abnormalities in isolated murine RyR2-P2328S hearts. Acta Physiol 2013; 207: 308-23.
22. King JH, Wickramarachchi C, Kua K et al. Loss of Nav1.5 expression and function in murine atria containing the RyR2-P2328S gain-of-function mutation. Cardiovasc Res. 2013;99:751-9.
23. Kottkamp H. Fibrotic atrial cardiomyopathy: a specific disease/syndrome supplying substrates for atrial fibrillation, atrial tachycardia, sinus node disease, AV node disease, and thromboembolic complications. J Cardiovasc Electrophysiol 2012; 23: 797-9.
24. Aime-Sempe C, Folliguet T, Rucker-Martin C et al. Myocardial cell death in fibrillating and dilated human right atria. J Am Coll Cardiol 1999; 34: 1577-86.
25. Smith JG, Newton-Cheh C, Almgren P et al. Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation. J Am Coll Cardiol 2010; 56: 1712-9.
26. Smith JG, Platonov PG, Hedblad B, Engstrom G, Melander O. Atrial fibrillation in the Malmo Diet and Cancer study: a study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol 2010; 25: 95-102.
27. Gramley F, Lorenzen J, Knackstedt C et al. Age-related atrial fibrosis. Age 2009; 31: 27-38.
28. Platonov PG, Mitrofanova LB, Orshanskaya V, Ho SY. Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. J Am Coll Cardiol 2011; 58: 2225-32.
29. Corradi D, Callegari S, Manotti L et al. Persistent lone atrial fibrillation: clinicopathologic study of 19 cases. Heart Rhythm 2014; 11: 1250-8.
30. Mahnkopf C, Badger TJ, Burgon NS et al. Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation. Heart Rhythm 2010; 7: 1475-81.
31. Boldt A, Wetzel U, Lauschke J et al. Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. Heart 2004; 90: 400-5.
32. Teh AW, Kistler PM, Lee G et al. Long-term effects of catheter ablation for lone atrial fibrillation: progressive atrial electroanatomic substrate remodeling despite successful ablation. Heart Rhythm 2012; 9: 473-80.
33. Moe GK, Abildskov JA. Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. Am Heart J 1959; 58: 59-70.
34. Allessie MA, Lammers W.J.E.P. et al. Experimental evaluation of Moe's multiple wavelet hypothesis of atrial fibrillation. In: Zipes DP, Jalife J, eds. Cardiac Arrhythmias. New York: Grune & Stratton, 1985; 265-76.
35. Cuculich PS, Wang Y, Lindsay BD et al. Noninvasive characterization of epicardial activation in humans with diverse atrial fibrillation patterns. Circulation 2010; 122: 1364-72.
36. Lee G, Kumar S, Teh A et al. Epicardial wave mapping in human long-lasting persistent atrial fibrillation: transient rotational circuits, complex wavefronts, and disorganized activity. Eur Heart J 2014; 35: 86-97.
37. Allessie MA, de Groot NM, Houben RP et al. Electropathological substrate of long-standing persistent atrial fibrillation in patients with structural heart disease: longitudinal dissociation. Circ Arrhythm Electrophysiol 2010; 3: 606-15.
38. Garrey W. Auricular fibrillation. Physiol Rev 1924; 4: 215-250.
39. Allessie MA, Bonke FI, Schopman FJ. Circus movement in rabbit atrial muscle as a mechanism of trachycardia. Circ Res 1973; 33: 54-62.
40. Mandapati R, Skanes A, Chen J, Berenfeld O, Jalife J. Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart. Circulation 2000; 101: 194-9.
41. Narayan SM, Krummen DE, Shivkumar K, Clopton P, Rappel WJ, Miller JM. Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. J Am Coll Cardiol 2012; 60: 628-36.
42. Swarup V, Baykaner T, Rostamian A et al. Stability of rotors and focal sources for human atrial fibrillation: focal impulse and rotor mapping (FIRM) of AF sources and fibrillatory conduction. J Cardiovasc Electrophysiol 2014; 25: 1284-92.
43. Miller JM, Kowal RC, Swarup V et al. Initial independent outcomes from focal impulse and rotor modulation ablation for atrial fibrillation: multicenter FIRM registry. J Cardiovasc Electrophysiol 2014; 25: 921-9.
44. Haissaguerre M, Hocini M, Denis A et al. Driver domains in persistent atrial fibrillation. Circulation 2014; 130: 530-8.
45. Kuklik P, Zeemering S, Maesen B et al. Reconstruction of instantaneous phase of unipolar atrial contact electrogram using a concept of sinusoidal recomposition and Hilbert transform. IEEE Transact Biomed Eng 2015; 62: 296-302.
46. Maesen B, Zeemering S, Afonso C et al. Rearrangement of atrial bundle architecture and consequent changes in anisotropy of conduction constitute the 3-dimensional substrate for atrial fibrillation. Circ Arrhythm Electrophysiol 2013; 6: 967-75.
47. Zeemering S, Maesen B, Nijs J et al. Automated quantification of atrial fibrillation complexity by probabilistic electrogram analysis and fibrillation wave reconstruction. Conf Proc IEEE Eng Med Biol Soc 2012; 2012: 6357-60.
48. Anne W, Willems R, Roskams T et al. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation. Cardiovasc Res 2005; 67: 655-66.
49. Chimenti C, Russo MA, Carpi A, Frustaci A. Histological substrate of human atrial fibrillation. Biomed Pharmacother. 2010;64:177-83.
50. Eckstein J, Zeemering S, Linz D et al. Transmural conduction is the predominant mechanism of breakthrough during atrial fibrillation: evidence from simultaneous endo-epicardial high-density activation mapping. Circ Arrhythm Electrophysiol 2013; 6: 334-41.
51. Verheule S, Tuyls E, Gharaviri A et al. Loss of continuity in the thin epicardial layer because of endomysial fibrosis increases the complexity of atrial fibrillatory conduction. Circ Arrhythm Electrophysiol 2013; 6: 202-11.
52. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997; 96: 1180-4.
53. Venteclef N, Guglielmi V, Balse E et al. Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. Eur Heart J 2015; 36: 795-805a.
54. Hatem SN, Sanders P. Epicardial adipose tissue and atrial fibrillation. Cardiovasc Res 2014; 102: 205-13.
55. Leone O, Boriani G, Chiappini B et al. Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation. Eur Heart J 2004; 25: 1237-41.
56. Rocken C, Peters B, Juenemann G et al. Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation. Circulation 2002; 106: 2091-7.
57. Polontchouk L, Haefliger JA, Ebelt B et al. Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria. J Am Coll Cardiol 2001; 38: 883-91.
58. Spach MS, Heidlage JF, Barr RC, Dolber PC. Cell size and communication: role in structural and electrical development and remodeling of the heart. Heart Rhythm 2004; 1: 500-15.
59. 2+ currents and human atrial fibrillation. Circ Res 1999; 85: 428-36.
60. Dobrev D, Friedrich A, Voigt N et al. The G protein-gated potassium current I(K, ACh) is constitutively active in patients with chronic atrial fibrillation. Circulation 2005; 112: 3697-706.
61. Chen PS, Chen LS, Fishbein MC, Lin SF, Nattel S. Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy. Circ Res 2014; 114: 1500-15.
62. Nguyen BL, Fishbein MC, Chen LS, Chen PS, Masroor S. Histopathological substrate for chronic atrial fibrillation in humans. Heart Rhythm 2009; 6: 454-60.
63. Skalidis EI, Hamilos MI, Karalis IK, Chlouverakis G, Kochiadakis GE, Vardas PE. Isolated atrial microvascular dysfunction in patients with lone recurrent atrial fibrillation. J Am Coll Cardiol 2008; 51: 2053-7.
64. Cai H, Li Z, Goette A et al. Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke. Circulation 2002; 106: 2854-8.